Literature DB >> 7669186

Synthesis and antiproliferative activity of furocoumarin isosters.

A Guiotto1, A Chilin, P Manzini, F Dall'Acqua, F Bordin, P Rodighiero.   

Abstract

Furocoumarins are a group of natural and synthetic compounds, some of which are used for the photochemotherapeutic treatment of certain skin diseases. With the aim of decreasing the side-effects of furocoumarin photochemotherapy and possibly increasing the therapeutic effects of these drugs, some new furocoumarin isosters were synthesized. The chemical synthesis of furocoumarin isosters at the furan ring, such as pyrrolo-, thieno-, oxazolo- and triazolocoumarins are reported. For all these compounds the key intermediate is a properly functionalized coumarin, to which the third heterocyclic ring is condensed by successive steps. Linear and angular pyrrolo-, tetrahydrobenzo- and benzopyrrolocoumarins show reduced photobiological activity, but have a strong antiproliferative effect in the dark, probably through an interaction with topoisomerases. Oxazolocoumarins are too unstable to be studied; triazolocoumarins show very poor activity. Tienocoumarins have not yet been studied. Furocoumarin isosters at the benzene ring are represented by 8-azapsoralens. Chemical synthesis involves the key 8-azacoumarin in the place of coumarin. These compounds have photochemical and photobiological properties which are very similar to those of psoralens. In particular, 4,4',5'- is effective in the photochemotherapeutic treatment of psoriasis. Furoquinolinones and 4-azapsoralens are reported among the isosters at the pyrone ring. While the synthesis of pyrroloquinolinones involves properly functionalized 7-aminoquinolinones as key intermediate, that of 4-azapsoralen requires a quite different synthetic pathway, involving a properly functionalized benzofuran derivative as key intermediate. Furoquinolinones have dramatically high activity both in the dark and under light activation; 4-azapsoralens have not yet been investigated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669186

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  6 in total

Review 1.  New synthetic routes to furocoumarins and their analogs: a review.

Authors:  Valery F Traven
Journal:  Molecules       Date:  2004-02-28       Impact factor: 4.411

Review 2.  Anti-microbial photodynamic therapy: useful in the future?

Authors:  Tim Maisch
Journal:  Lasers Med Sci       Date:  2006-11-21       Impact factor: 2.555

3.  Differential Effects of Angelicin Analogues on NF-κB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells.

Authors:  Ilaria Lampronti; Maria Giulia Manzione; Gianni Sacchetti; Davide Ferrari; Susanna Spisani; Valentino Bezzerri; Alessia Finotti; Monica Borgatti; Maria Cristina Dechecchi; Giorgia Miolo; Giovanni Marzaro; Giulio Cabrini; Roberto Gambari; Adriana Chilin
Journal:  Mediators Inflamm       Date:  2017-09-27       Impact factor: 4.711

4.  Synthesis of new substituted chromen[4,3-c]pyrazol-4-ones and their antioxidant activities.

Authors:  Abdullah Sulaiman Al-Ayed
Journal:  Molecules       Date:  2011-12-12       Impact factor: 4.411

5.  Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators.

Authors:  Onofrio Laselva; Giovanni Marzaro; Christian Vaccarin; Ilaria Lampronti; Anna Tamanini; Giuseppe Lippi; Roberto Gambari; Giulio Cabrini; Christine E Bear; Adriana Chilin; Maria C Dechecchi
Journal:  Front Pharmacol       Date:  2018-07-04       Impact factor: 5.810

6.  3-[1-(2-Hy-droxy-anilino)ethyl-idene]-3H-chromen-2,4-dione.

Authors:  Ameni Brahmia; Taicir Ben Ayed; Rached Ben Hassen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.